Squamous Cell Carcinomas of the Head and Neck Cancer Response to Programmed Cell Death Protein-1 Targeting and Differential Expression of Immunological Markers: A Case Report

Targeting the programmed cell death protein-1 (PD-1)/PD-1 ligand (PD-L1) pathway has been shown to enhance T cell-mediated antitumor immunity. Clinical responses are limited to subgroups of patients. The search for biomarkers of response is a strategy to predict response and outcome of PD-1/PD-L1 ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Merhi, Maysaloun, Raza, Afsheen, Inchakalody, Varghese Philipose, Nashwan, Abdulqadir Jeprel Japer, Allahverdi, Niloofar, Krishnankutty, Roopesh, Uddin, Shahab, Zar Gul, Abdul Rehman, Al Homsi, Mohammed Ussama, Dermime, Said
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079623/
https://www.ncbi.nlm.nih.gov/pubmed/30108590
http://dx.doi.org/10.3389/fimmu.2018.01769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079623/
https://www.ncbi.nlm.nih.gov/pubmed/30108590
http://dx.doi.org/10.3389/fimmu.2018.01769

Ejemplares similares